US Patent Issued to Tavotek Biotherapeutics (Hong Kong) on Oct. 7 for "Agents that interfere with thymic stromal lymphopoietin (TSLP)-receptor signaling" (Pennsylvania, New Jersey Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,131, issued on Oct. 7, was assigned to Tavotek Biotherapeutics (Hong Kong) Ltd. (Hong Kong).

"Agents that interfere with thymic stromal lymphopoietin (TSLP)-receptor signaling" was invented by Susan H. Tam (Garnet Valley, Pa.), Di Zhang (Hillsborough, N.J.), Lihua Shi (Wynnewood, Pa.) and Man-Cheong Fung (Ringoes, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is related to antibodies (e.g., human antibodies) and antigen-binding fragments thereof that specifically bind and neutralize (human) thymic stromal lymphopoietin (TSLP). Such molecules may have modified Fc regions that increase antibody half-life, increase resistanc...